Literature DB >> 33558668

Circadian rhythm of the intrarenal renin-angiotensin system is caused by glomerular filtration of liver-derived angiotensinogen depending on glomerular capillary pressure in adriamycin nephropathy rats.

Takashi Matsuyama1, Naro Ohashi2, Taro Aoki1, Sayaka Ishigaki3, Shinsuke Isobe1, Taichi Sato1, Tomoyuki Fujikura1, Akihiko Kato3, Hiroaki Miyajima1, Hideo Yasuda1.   

Abstract

Circadian fluctuation disorder of the intrarenal renin-angiotensin system (RAS) causes that of blood pressure (BP) and renal damage. In renal damage with an impaired glomerular filtration barrier, liver-derived angiotensinogen (AGT) filtered through damaged glomeruli regulates intrarenal RAS activity. Furthermore, glomerular permeability is more strongly affected by glomerular hypertension than by systemic hypertension. Thus, we aimed to clarify whether the circadian rhythm of intrarenal RAS activity is influenced by AGT filtered through damaged glomeruli due to glomerular capillary pressure. Rats with adriamycin nephropathy and an impaired glomerular filtration barrier were compared with control rats. In adriamycin nephropathy rats, olmesartan medoxomil (an angiotensin II type 1 receptor blocker) or hydralazine (a vasodilator) was administered, and the levels of intrarenal RAS components in the active and rest phases were evaluated. Moreover, the diameter ratio of afferent to efferent arterioles (A/E ratio), an indicator of glomerular capillary pressure, and the glomerular sieving coefficient (GSC) based on multiphoton microscopy in vivo imaging, which reflects glomerular permeability, were determined. Mild renal dysfunction was induced, and the systemic BP increased, resulting in increased A/E ratios in the adriamycin nephropathy rats compared with the control rats. Fluctuations in intrarenal RAS activity occurred in parallel with circadian fluctuations in glomerular capillary pressure, which disappeared with olmesartan treatment and were maintained with hydralazine treatment. Furthermore, the GSCs for AGT also showed similar changes. In conclusion, intrarenal RAS activity is influenced by the filtration of liver-derived AGT from damaged glomeruli due to circadian fluctuation disorder of the glomerular capillary pressure.

Entities:  

Keywords:  Adriamycin nephropathy; Circadian rhythm; Glomerular capillary pressure; Intrarenal renin–angiotensin system; Multiphoton microscopy

Mesh:

Substances:

Year:  2021        PMID: 33558668     DOI: 10.1038/s41440-021-00620-6

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  35 in total

1.  Diurnal variation of plasma angiotensin II in man.

Authors:  R Kala; F Fyhrquist; A Eisalo
Journal:  Scand J Clin Lab Invest       Date:  1973-06       Impact factor: 1.713

2.  A diurnal rhythm in plasma renin activity in man.

Authors:  R D Gordon; L K Wolfe; D P Island; G W Liddle
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

3.  Circadian rhythm of the renin-angiotensin-aldosterone system in the rat.

Authors:  M Hilfenhaus
Journal:  Arch Toxicol       Date:  1976-12-17       Impact factor: 5.153

4.  Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass.

Authors:  J L Olson; T H Hostetter; H G Rennke; B M Brenner; M A Venkatachalam
Journal:  Kidney Int       Date:  1982-08       Impact factor: 10.612

5.  Multiphoton imaging of the glomerular permeability of angiotensinogen.

Authors:  Daisuke Nakano; Hiroyuki Kobori; James L Burford; Haykanush Gevorgyan; Saskia Seidel; Hirofumi Hitomi; Akira Nishiyama; Janos Peti-Peterdi
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

Review 6.  Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

7.  Liver angiotensinogen is the primary source of renal angiotensin II.

Authors:  Taiji Matsusaka; Fumio Niimura; Akihiro Shimizu; Ira Pastan; Akihiko Saito; Hiroyuki Kobori; Akira Nishiyama; Iekuni Ichikawa
Journal:  J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 10.121

8.  Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Takayuki Tsuji; Yukitoshi Sakao; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki; Akira Nishiyama; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-01-07       Impact factor: 3.872

9.  Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.

Authors:  Shinsuke Isobe; Naro Ohashi; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2014-04-12       Impact factor: 2.801

10.  Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.

Authors:  Yoko Nishijima; Hiroyuki Kobori; Kumiko Kaifu; Tomoko Mizushige; Taiga Hara; Akira Nishiyama; Masakazu Kohno
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-11-07       Impact factor: 1.636

View more
  2 in total

Review 1.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 2.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.